NCIC Publications

Diagnosis, management and prevention of Candida auris in hospitals: Position statement of the Australasian Society for Infectious Diseases.

Ong CW, Chen SC, Clark JE, Halliday CL, Kidd SE, Marriott DJ, Marshall CL, Morris AJ, Morrissey CO, Roy R, Slavin MA, Stewardson AJ, Worth LJ, Heath CH; Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Hospital Infection Special Interest Group (HICSIG); both of the Australasian Society for Infectious Diseases (ASID).

Intern Med J. 2019 Aug 19. doi: 10.1111/imj.14612

Mycobacterium abscessus bloodstream infection: Unexpected catheter tunnel infection localized by PET/CT.

Xie O, Khan S, Globan M, Lea K, Bajel A, Slavin M.

Transpl Infect Dis. 2019 Jul 15:e13147. doi: 10.1111/tid.13147

Sepsis incidence and mortality are underestimated in Australian intensive care unit administrative data

Jake C Valentine, Gabrielle Haeusler, Leon Worth and Karin Thursky

Med J Aust March 2019. doi: 10.5694/mja2.50017

New Advances in the Management of Cytomegalovirus in Allogeneic Haemopoietic Stem Cell Transplantation

Michelle K. Yong, David Gottlieb, Julian Lindsay, Jen Kok, William Rawlinson, Monica Slavin, David Ritchie, Ashish Bajel, Andrew Grigg.

International Medicine Journal. 2019 Aug.

The current scope of healthcare-associated infection surveillance activities in hospitalized immunocompromised patients: a systematic review.

Valentine JC, Hall L, Verspoor KM, Worth LJ.

Int J Epidemiol. 2019 Jul 30. pii: dyz162. doi: 10.1093/ije/dyz162

High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing.

Meher-Homji Z, Tam CS, Siderov J, Seymour JF, Holmes NE, Chua KYL, Phillips EJ, Slavin MA, Trubiano JA.

Leuk Lymphoma. 2019 Jul 1:1-6. doi: 10.1080/10428194.2019.1633640.

Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host.

Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2019 Jun 13. pii: S2213-2198(19)30547-1. doi: 10.1016/j.jaip.2019.05.051

Diagnosis and treatment of invasive fungal infections: looking ahead.

Sanguinetti M, Posteraro B, Beigelman-Aubry C, Lamoth F, Dunet V, Slavin M, Richardson MD.

J Antimicrob Chemother. 2019 Mar 1;74(Supplement_2):ii27-ii37. doi: 10.1093/jac/dkz041

Microbiome transplantation and modulation of immune related adverse events.

Smibert OC, Guo CW, Khoo C, Thursky KA, Sandhu S, Slavin MA.

EClinicalMedicine. 2019 Mar 12;8:10-11. doi: 10.1016/j.eclinm.2019.03.003. eCollection 2019 Feb

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.

Keighley C, Chen SC, Marriott D, Pope A, Chapman B, Kennedy K, Bak N, Underwood N, Wilson HL, McDonald K, Darvall J, Halliday C, Kidd S, Nguyen Q, Hajkowicz K, Sorrell TC, Van Hal S, Slavin MA.

BMC Infect Dis. 2019 May 21;19(1):445. doi: 10.1186/s12879-019-4065-5

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement.

Doyle J, Raggatt M, Slavin M, McLachlan SA, Strasser SI, Sasadeusz JJ, Howell J, Hajkowicz K, Nandurkar H, Johnston A, Bak N, Thompson AJ.

Med J Aust. 2019 Jun;210(10):462-468. doi: 10.5694/mja2.50160. Epub 2019 May 19

Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program.

Paige E, Haywood P, Xie M, Worth L, Thursky K, Urbancic K, Bajel A, Slavin M.

Leuk Lymphoma. 2019 May 17:1-11. doi: 10.1080/10428194.2019.1590570. [Epub ahead of print]

Management and prevention of cytomegalovirus infection in paediatric hematopoietic stem cell transplant (HSCT) recipients: A binational survey

Yazidi L, Mitchell R, Palasanthiran P, O’Brien T, McMullan B.

Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre.

Hiong A, Thursky KA, Venn G, Teh BW, Haeusler GM, Crane M, Slavin MA, Worth LJ.

Eur J Cancer Care (Engl). 2019 Feb 13:e13018. doi: 10.1111/ecc.13018.

Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression.

Slavin MA, Worth LJ, Seymour JF, Thursky KA.

J Clin Oncol. 2019 Mar 7:JCO1801474. doi: 10.1200/JCO.18.01474.

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Leuk Lymphoma. 2019 Apr 5:1-6. doi: 10.1080/10428194.2019.1590571.

Antibiotic allergy.

Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ.

Lancet. 2019 Jan 12;393(10167):183-198. doi: 10.1016/S0140-6736(18)32218-9.

Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types.

Biswas C, Marcelino VR, Van Hal S, Halliday C, Martinez E, Wang Q, Kidd S, Kennedy K, Marriott D, Morrissey CO, Arthur I, Weeks K, Slavin MA, Sorrell TC, Sintchenko V, Meyer W, Chen SC.

Front Microbiol. 2018 Dec 3;9:2946. doi: 10.3389/fmicb.2018.02946.

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®.

Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA, Bachmann B, Borchert K, Burchardt A, Chakrabarti A, Christopeit M, Fasih N, Hekmat K, Hernández Rupérez B, Kemmerling B, Kessel J, Jyoti Kindo A, Klimko N, Krause R, Lass-Flörl C, Levesque E, Lockhart S, Steinmann J, Maritati A, Markiefka B, Martín Gómez MT, Meis J, Oksi J, Pagano L, Ramos Martinez A, Reischies F, Soler Palacin P, Vermeulen E.

Crit Rev Microbiol. 2019 Jan 10:1-21. doi: 10.1080/1040841X.2018.1514366.

The contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports.

Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Chen SC, Kong DCM.

Int J Antimicrob Agents. 2019 Jan doi: 10.1016/j.ijantimicag.2019.01.002

Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.

Douglas AP, Marshall C, Baines SL, Ritchie D, Szer J, Madigan V, Chan HT, Ballard SA, Howden BP, Buising K, Slavin MA.

J Med Microbiol. 2019 Jan doi: 10.1099/jmm.0.000916.

High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia

Teh BW, Chui W, Handunnetti S, Tam C, Worth LJ, Thursky KA, Slavin MA.

Leuk Lymphoma. 2019 Jan doi: 10.1080/10428194.2018.1543884.

The safety and efficacy of an oral penicillin challenge program in cancer patients – A pilot multicentre study 

Jason A Trubiano, Olivia Smibert, Abby Douglas, Misha Devchand, Belinda Lambros, Natasha E Holmes, Kyra Y Chua, Elizabeth J Phillips, Monica A Slavin

Open Forum Infectious Diseases 2018 Nov

Antifungal stewardship: developments in the field.

Urbancic KF, Thursky K, Kong DCM, Johnson PDR, Slavin MA.

Curr Opin Infect Dis. 2018 Oct 5. doi: 10.1097/QCO.0000000000000497

Invasive fungal disease and cytomegalovirus infection: is there an association?

Yong MK, Slavin M, Kontoyiannis DP.

Curr Opin Infect Dis. 2018 Oct 5. doi: 10.1097/QCO.0000000000000502.

The Safety of Antibiotic Skin Testing in Severe T-cell-Mediated Hypersensitivity of immunocompetent and immunocompromised hosts.

Trubiano JA, Douglas AP, Goh M, Slavin MA, Phillips EJ.

J Allergy Clin Immunol Pract. 2018 Sep 25. doi: 10.1016/j.jaip.2018.09.014.

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients.

Diorio C, Robinson PD, Ammann RA, Castagnola E, Erickson K, Esbenshade A, Fisher BT, Haeusler GM, Kuczynski S, Lehrnbecher T, Phillips R, Cabral S, Dupuis LL, Sung L.

J Clin Oncol. 2018 Sep 14:JCO1800407. doi: 10.1200/JCO.18.00407

Access, knowledge and experience with FDG-PET/CT in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Intern Med J. 2018 Sep 19. doi: 10.1111/imj.14117

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL).

J Antimicrob Chemother. Aug 2018 doi: 10.1093/jac/dky286 

Global Guidelines and Initiatives from the European Confederation of Medical Mycology to improve Patient Care and Research Worldwide: New Leadership is about Working Together

Martin Hoenigl, Jean‐Pierre Gangneux, Esther Segal, Alexandre Alanio, Arunaloke Chakrabarti, Sharon C‐A. Chen, Nelesh Govender, Ferry Hagen, Nikolaj Klimko, Jacques F. Meis

Mycoses. Aug 2018

Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer

Jason A Trubiano M Lindsay Grayson Elizabeth J Phillips Andrew J Stewardson Karin A Thursky Monica A Slavin

Journal of Antimicrobial Chemotherapy. July 2018 doi:

Dapsone safety in haematology patients: pathways to optimising Pneumocystis jirovecii pneumonia prophylaxis in haematology malignancy and transplant recipients.

Urbancic KF, Pisasale D, Wight J, Trubiano JA.

Transpl Infect Dis.July 2018 doi: 10.1111/tid.12968

The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.

Jeong W, Keighley C, Wolfe R, Leng Lee W, Slavin MA, Kong DCM, Chen SC.

Clin Microbiol Infect. July 2018 doi: 10.1016/j.cmi.2018.07.011

Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs.

Thursky K, Lingaratnam S, Jayarajan J, Haeusler GM, Teh B, Tew M, Venn G, Hiong A, Brown C, Leung V, Worth LJ, Dalziel K, Slavin MA.

BMJ Open Qual. Jun 2018  doi: 10.1136/bmjoq-2018-000355

How antibiotic allergy labels may be harming our most vulnerable patients.

Trubiano JA, Grayson ML, Thursky KA, Phillips EJ, Slavin MA.

Med J Aust. Jun 2018 PMID 29902399

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, Slavin MA.

Eur J Nucl Med Mol Imaging. Jun 2018  doi: 10.1007/s00259-018-4062-8

Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies.

Teh BW, Tam CS, Handunnetti S, Worth LJ, Slavin MA.

Blood Rev. April 2018 doi: 10.1016/j.blre.2018.04.007

Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.

Haeusler GM, Slavin MA, Bryant PA, Babl FE, Mechinaud F, Thursky KA.

J Paediatr Child Health. Apr 2018  doi: 10.1111/jpc.13899

Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing.

Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW.

Biol Blood Marrow Transplant. March 2018 doi: 10.1016/j.bbmt.2018.03.004

Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.

Surtees TC, Teh BW, Slavin MA, Worth LJ.

Vaccine.March 2018 doi: 10.1016/j.vaccine.2018.02.098

In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.

Biswas C, Law D, Birch M, Halliday C, Sorrell TC, Rex J, Slavin M, Chen SC.

Med Mycol. Jan 2018 doi: 10.1093/mmy/myx161

Pharmacokinetics and safety results from the phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Cornely O, Robertson M, Haider S, Grigg AP, et al.

J Antimicrob Chemother Jan 2018

Limited utility of routine chest X-ray in initial evaluation of neutropenic fever (NF) in patients with haematological diseases undergoing chemotherapy

Estacio O, Loh Z, Baker A, Chong G, Grigg AP, Churilov L, Hawkes EA.

Int Med J Jan 2018 :  DOI: 10.1111/imj.13712, 2018

ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.

Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH; ECIL-6 Group.

J Antimicrob Chemother. 2018 Jan 1;73(1):12-21.doi: 10.1093/jac/dkx324.

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.

Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C; European Conference on Infections in Leukemia (ECIL).

J Infect.Jan 2018  doi: 10.1016/j.jinf.2017.10.009

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.

Biswas C, Chen SC, Halliday C, Martinez E, Rockett RJ, Wang Q, Timms VJ, Dhakal R, Sadsad R, Kennedy KJ, Playford G, Marriott DJ, Slavin MA, Sorrell TC, Sintchenko V.

J Vis Exp. Dec 2017  doi: 10.3791/56714.

Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.

Jeong W, Snell GI, Levvey BJ, Westall GP, Morrissey CO, Wolfe R, Ivulich S, Neoh CF, Slavin MA, Kong DCM.

J Antimicrob Chemother. 2017 Dec doi: 10.1093/jac/dkx440

What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer.

Douglas A, Lau E, Thursky K, Slavin M.

Curr Opin Infect Dis. 2017 Dec;30(6):552-564. doi: 10.1097/QCO.0000000000000405.

Impact of a dedicated post-transplant vaccination service at an Australian cancer centre.

Teh BW, Joyce T, Slavin MA, Thursky KA, Worth LJ.

Bone Marrow Transplant. 2017 Dec;52(12):1681-1683. doi: 10.1038/bmt.2017.195

Cart before the horse: use of Aspergillus PCR to increase the diagnostic yield from BAL in hematological patients at risk of invasive aspergillosis.

Smibert OC, Slavin MA.

Leuk Lymphoma. Dec 2017 doi: 10.1080/10428194.2017.1330479.

The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ.

J Allergy Clin Immunol Pract. Nov 2017 doi: 10.1016/j.jaip.2017.06.017

Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Yong MK, Cameron PU, Slavin MA, Cheng AC, Morrissey CO, Bergin K, Spencer A, Ritchie D, Lewin SR.

Front Immunol. Nov 2017 doi: 10.3389/fimmu.2017.01506

Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.

Yong MK, Ananda-Rajah M, Cameron PU, Morrissey CO, Spencer A, Ritchie D, Cheng AC, Lewin SR, Slavin M.

Biol Blood Marrow Transplant. Nov 2017 doi: 10.1016/j.bbmt.2017.07.025

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.

Colombo AL, de Almeida Júnior JN, Slavin MA, Chen SC, Sorrell TC.

Lancet Infect Dis. Nov 2017 doi: 10.1016/S1473-3099(17)30304-3.

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.

Blyth CC, Haeusler GM, McMullan BJ, Kotecha RS, Slavin MA, Clark JE.

Support Care Cancer. 2017 Nov doi: 10.1007/s00520-017-3681-0.

The Combined Utility of Ex vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In vivo Skin Testing in Patients With Antibiotic-Associated Severe Cutaneous Adverse Reactions.

Trubiano JA, Strautins K, Redwood AJ, Pavlos R, Konvinse KC, Aung AK, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2017 Oct doi: 10.1016/j.jaip.2017.09.004

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.

Teh BW, Harrison SJ, Allison CC, Slavin MA, Spelman T, Worth LJ, Thursky KA, Ritchie D, Pellegrini M.

Front Immunol. 2017 Oct . doi: 10.3389/fimmu.2017.01247

Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.

Teh BW, Brown C, Joyce T, Worth LJ, Slavin MA, Thursky KA.

Support Care Cancer. 2017 Oct  doi: 10.1007/s00520-017-3921-3

Ibrutinib may impair serological responses to influenza vaccination.

Douglas AP, Trubiano JA, Barr I, Leung V, Slavin MA, Tam CS.

Haematologica. 2017 Oct. doi: 10.3324/haematol.2017.164285

Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes.

Trubiano JA, Dickinson M, Thursky KA, Spelman T, Seymour JF, Slavin MA, Worth LJ.

Leuk Lymphoma. 2017 Oct. doi: 10.1080/10428194.2017.1295141.

Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?

Macesic N, Morrissey CO, Liew D, Bohensky MA, Chen SC, Gilroy NM, Milliken ST, Szer J, Slavin MA.

Med Mycol. 2017 Oct doi: 10.1093/mmy/myw141.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis.Sept 2017 doi: 10.1093/ofid/ofx200

External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.

Haeusler GM, Thursky KA, Slavin MA, Mechinaud F, Babl FE, Bryant P, De Abreu Lourenco R, Phillips R.

Pediatr Infect Dis J. 2017 Sep doi: 10.1097/INF.0000000000001777

Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.

Biswas C, Chen SC, Halliday C, Kennedy K, Playford EG, Marriott DJ, Slavin MA, Sorrell TC, Sintchenko V.

Clin Microbiol Infect. 2017 Sep. doi: 10.1016/j.cmi.2017.03.014.

Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.

Haeusler GM, Thursky KA, Mechinaud F, Babl FE, De Abreu Lourenco R, Slavin MA, Phillips R.

Br J Cancer. 2017 Jul  doi: 10.1038/bjc.2017.154

Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.

Trubiano JA, Thursky KA, Stewardson AJ, Urbancic K, Worth LJ, Jackson C, Stevenson W, Sutherland M, Slavin MA, Grayson ML, Phillips EJ.

Clin Infect Dis. 2017 Jul doi: 10.1093/cid/cix244.

Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.

Jeong W, Snell GI, Levvey BJ, Westall GP, Morrissey CO, Ivulich S, Neoh CF, Slavin MA, Kong DCM.

J Antimicrob Chemother. 2017 Jul doi: 10.1093/jac/dkx085.

Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.

Yong MK, Cameron PU, Slavin M, Morrissey CO, Bergin K, Spencer A, Ritchie D, Cheng AC, Samri A, Carcelain G, Autran B, Lewin SR.

J Infect Dis. 2017 Jun doi: 10.1093/infdis/jix192.

Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.

Hebbard AIT, Slavin MA, Reed C, Trubiano JA, Teh BW, Haeusler GM, Thursky KA, Worth LJ.

Support Care Cancer. 2017 Jun doi: 10.1007/s00520-017-3606-y.

Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.

Leung VKY, Carolan LA, Worth LJ, Harper SA, Peck H, Tilmanis D, Laurie KL, Slavin MA, Sullivan SG.

Vaccine. 2017 May. doi: 10.1016/j.vaccine.2017.03.063.

Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.

Marks DI, Liu Q, Slavin M.

Expert Rev Anti Infect Ther. 2017 May. doi: 10.1080/14787210.2017.1305886.

Changing epidemiology of candidaemia in Australia.

Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S; Australian and New Zealand Mycoses Interest Group.

J Antimicrob Chemother. 2017 Apr  doi: 10.1093/jac/dkw422.

Erratum in: J Antimicrob Chemother. 2017 Apr .

Changing epidemiology of candidaemia in Australia.

Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S; Australian and New Zealand Mycoses Interest Group.

J Antimicrob Chemother. 2017 Apr. doi: 10.1093/jac/dkx047.

New developments and directions in the clinical application of the echinocandins.

Chang CC, Slavin MA, Chen SC.

Arch Toxicol. 2017 Apr. doi: 10.1007/s00204-016-1916-3.

Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.

Teh BW, Harrison SJ, Slavin MA, Worth LJ.

Eur J Haematol. 2017 Feb. doi: 10.1111/ejh.12813.

Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.

Solano C, Slavin M, Shaul AJ, Marks DI, Cordonnier C, Cornely OA, Pagliuca A, Cragin L, Jarque I, Garcia-Vidal C, Sorensen S, Vanness DJ, Charbonneau C, Barrueta JA, Peral C, De Salas-Cansado M, Bow EJ.

Mycoses. 2017 Feb. doi: 10.1111/myc.12552.